Carregant...

Fingolimod and changes in hematocrit, hemoglobin and red blood cells of patients with multiple sclerosis

Introduction: Fingolimod is the first oral drug approved by Food and Drug Administration (FDA) of United States for treating patients with relapsing-remitting multiple sclerosis (RRMS). Fingolimod acts by immunomodulation but there are still much remained about its different effects. Objectives: The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Clin Exp Immunol
Autors principals: Momeni, Ali, Abrishamkar, Rana, Panahi, Fatemeh, Eslami, Sepehr, Tavoosi, Nooshin, Rafiee Zadeh, Aryan
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726974/
https://ncbi.nlm.nih.gov/pubmed/31497380
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!